Results

Total Results: 1,112 records

Showing results for "phase".

241. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0002_03-04-2008.pdf
     January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

242. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0351_05-10-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

243. Disposition of Comments for CER 160 Binge Eating Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
     December 09, 2015 - The McElroy (2014) report on the lisdexamfetamine Phase 2 trial has been added to the report. … McElroy, APA 2013: this report of the Phase 2 trial was excluded because it is duplicative to the Phase … This report of the Phase 2 trial was excluded because it is duplicative to the Phase 2 results presented … 2 and Phase 3)….among individuals with BED.” … We have included the Phase 2 trial in our review.

244. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Lorcaserin is therefore in an early diffusion phase. … FDA approved the drug on July 17, 2012, on the basis of two completed, phase III trials. … Liraglutide is under investigation in a four-part phase III clinical trial (SCALE). … FDA approved the drug on June 27, 2012, on the basis of three completed phase III trials. … Novo Nordisk reports 8% weight loss in phase 3a obesity trial with liraglutide 3 mg.

245. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0488_12-27-2011.pdf
     January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

246. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0645-151012.pdf
     August 05, 2015 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

247. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/chewing-gum-covid-19-prevention
     July 17, 2020 - Home » Get Involved » Nominated Topics » Topic Suggestion Description Topic Suggestion Description Date submitted: July 17, 2020 Download Topic Suggestion Disposition [PDF · 220 KB] Chewing Gum for COVID-19 Prevention 1. What is the decision or change you are facing …

248. Advancing Registry Methodology and Transparency | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/registry-of-patient-registries/advancing-registry-methodology-and-transparency
     December 06, 2019 - Advancing Registry Methodology and Transparency Abstract December 6, 2019 Advancing Registry Methodology and Transparency A patient registry is an organized system that uses observational research methods to collect data for the scientific assessment of patient outcomes. Patient registries are an impo…

249. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - to determine Peer reviewer #5 Executive Summary ES-12 Table needs to be more specific –luteal phase … The Kaunitz study (57) is RCT using “luteal phase” or cyclic MPA. … We clarified that “ MPA administered during the luteal phase of the cycle” Peer Reviewer #7 (TEP … I f we mean luteal phase progestins or daily oral or vaginal progestins, that should be stated. … the luteal phase, elevated levels of systematic estradiol, and associated heavy uterine bleeding.

250. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-1.pdf
     March 01, 2022 - Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese … treatment of migraine: pooled efficacy, safety, and tolerability from the ACHIEVE I and ACHIEVE II phase … pain burden in patients with treatment- resistant migraine: effects of galcanezumab in the CONQUER Phase … Ubrogepant for the acute treatment of migraine: pooled efficacy from ACHIEVE I and ACHIEVE II phase … Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase

251. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) at least preliminary phase III data were … Expert comments led to designation of one RA therapy in phase III development as having high potential … In a phase III, double-blind, 6-month study, adult patients (n=611) with active RA—whose symptoms did … Pfizer's tofacitinib meets endpoints in final phase III trials.

252. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - Shouldn't you include the results of the phase III study by Eng et al? 2. … treated with Naglazyme in the Phase III pivotal trial … the phase II/III study which is the largest clinical trial in Hunter syndrome. … II/III study and the phase ll/lll extension study. 4. … Please include open label extension of Muenzer phase II/III study.

253. Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
     May 01, 2022 - Only Phase 2 included rooms housing patients with CDI. … Acute care tertiary care facility NR PX-UV (Xenex; Xenex Disinfection Services) Phase I: (16 rooms … Phase II: (24 rooms) Standard terminal cleaning* vs. … Phase 1: PX-UV • Before: 11.6% positive (13/112) • After: 2.7% positive (3/112), p<0.01 Phase … “Cleaning phase” + Manual cleaning (0.5% sodium hypochlorite solution) *Cleaning phase only described

254. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - adrenergic agonist - Increases bladder capacity by relaxing the bladdersmooth muscle during the storage phase … 90. double blind method/ 91. single blind method/ 92. clinical trial/ 93. clinical trial, phase … i.pt. 94. clinical trial, phase ii.pt. 95. clinical trial, phase iii.pt. 96. clinical trial, phase … and Adverse Reactions"/ 124. exp Adverse Drug Reaction Reporting Systems/ 125. exp Clinical Trials, Phase … and Adverse Reactions"/ 111. exp Adverse Drug Reaction Reporting Systems/ 112. exp Clinical Trials, Phase

255. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
     January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

256. Topic 0533 Postpartum Hemorrhage NSD FINALsj (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0652-131114.pdf
     May 15, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

257. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0134_07-19-2009.pdf
     January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

258. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0255_06-25-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

259. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

260. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase